Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus

Biochemistry
Christopher J WoodsAdrian J Mulholland

Abstract

Multidrug resistance of the pandemic H1N1-2009 strain of influenza has been reported due to widespread treatment using the neuraminidase (NA) inhibitors, oseltamivir (Tamiflu), and zanamivir (Relenza). From clinical data, the single I223R (IR(1)) mutant of H1N1-2009 NA reduced efficacy of oseltamivir and zanamivir by 45 and 10 times, (1) respectively. More seriously, the efficacy of these two inhibitors against the double mutant I223R/H275Y (IRHY(2)) was significantly reduced by a factor of 12 374 and 21 times, respectively, compared to the wild-type.(2) This has led to the question of why the efficacy of the NA inhibitors is reduced by the occurrence of these mutations and, specifically, why the efficacy of oseltamivir against the double mutant IRHY was significantly reduced, to the point where oseltamivir has become an ineffective treatment. In this study, 1 μs of molecular dynamics (MD) simulations was performed to answer these questions. The simulations, run using graphical processors (GPUs), were used to investigate the effect of conformational change upon binding of the NA inhibitors oseltamivir and zanamivir in the wild-type and the IR and IRHY mutant strains. These long time scale dynamics simulations demonstrated that ...Continue Reading

References

Jun 1, 1995·Protein Science : a Publication of the Protein Society·J N VargheseP M Colman
Dec 1, 1993·Proteins·A AmadeiH J Berendsen
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Oct 31, 1998·Protein Engineering·I N Shindyalov, P E Bourne
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·N A BakerJ A McCammon
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Dec 24, 2005·The New England Journal of Medicine·Anne Moscona
Dec 2, 2006·Nature Reviews. Drug Discovery·Erik De Clercq
Jun 2, 2007·Journal of the American Chemical Society·Rommie E AmaroJ Andrew McCammon
Aug 21, 2007·Journal of Medical Virology·Phillip Andrew Reece
Aug 25, 2007·Bioinformatics·Michele SeeberAmedeo Caflisch
Dec 7, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Olivier Ferraris, Bruno Lina
May 16, 2008·Nature·Patrick J CollinsSteven J Gamblin
Aug 22, 2008·Journal of Virology·Xiaojin XuIan A Wilson
Nov 13, 2008·Amino Acids·Maturos MalaisreeSupot Hannongbua
Jul 6, 2010·Proteins·Morgan LawrenzJ Andrew McCammon
Sep 21, 2010·Nature Structural & Molecular Biology·Qing LiGeorge F Gao
Sep 23, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ha T NguyenLarisa V Gubareva
Oct 1, 2010·The New England Journal of Medicine·Erhard van der VriesCharles A B Boucher
Feb 10, 2011·The Journal of Chemical Physics·Christopher J WoodsAdrian J Mulholland
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L SwerdlowCarolyn B Bridges
Jun 10, 2011·Journal of Virology·Mingyang WangGeorge F Gao
Jul 14, 2011·Nature Communications·Rommie E AmaroRobin M Bush
Dec 25, 2012·Journal of Chemical Theory and Computation·T SteinbrecherD A Case
Sep 9, 2008·Journal of Chemical Theory and Computation·Ricky Chachra, Robert C Rizzo

❮ Previous
Next ❯

Citations

Jan 29, 2016·Current Opinion in Structural Biology·Giorgio Saladino, Francesco Luigi Gervasio
Dec 26, 2015·Journal of Chemical Information and Modeling·Muhammad YusufHabibah Wahab
Oct 27, 2015·Journal of Molecular Modeling·Gema L Ramírez-SalinasJ Correa-Basurto
Dec 21, 2013·Scientific Reports·Christopher J WoodsAdrian J Mulholland
Mar 13, 2013·EMBO Reports·Ivan Campeotto, Carlos G Acevedo-Rocha
Mar 13, 2014·Bioorganic & Medicinal Chemistry·Wael M Abdel-MageedLixin Zhang
Sep 25, 2012·Journal of Chemical Information and Modeling·Lin LiTingjun Hou
Nov 23, 2016·Future Medicinal Chemistry·Zhiwei YangGang Yang
Oct 11, 2014·Expert Review of Anti-infective Therapy·Nick SpanakisAthanassios Tsakris
Nov 16, 2017·Expert Opinion on Drug Discovery·Xuewei LiuXiaojun Yao
Dec 5, 2017·Journal of Biomolecular Structure & Dynamics·S Kannan, P Kolandaivel
Sep 28, 2017·Scientific Reports·Kai-Cheng HsuJinn-Moon Yang
Sep 5, 2019·Current Pharmaceutical Design·Indrani Bera, Pavan V Payghan
Mar 4, 2020·ACS Central Science·Jacob D DurrantRommie E Amaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.